[HTML][HTML] Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
D Lindén, A Ahnmark, P Pingitore, E Ciociola… - Molecular …, 2019 - Elsevier
Objective Nonalcoholic fatty liver disease (NAFLD) is becoming a leading cause of
advanced chronic liver disease. The progression of NAFLD, including nonalcoholic …
advanced chronic liver disease. The progression of NAFLD, including nonalcoholic …
Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
D Linden, A Ahnmark, P Pingitore, E Ciociola… - MOLECULAR …, 2019 - iris.unicz.it
Objective: Nonalcoholic fatty liver disease (NAFLD) is becoming a leading cause of
advanced chronic liver disease. The progression of NAFLD, including nonalcoholic …
advanced chronic liver disease. The progression of NAFLD, including nonalcoholic …
[HTML][HTML] Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
D Lindén, A Ahnmark, P Pingitore, E Ciociola… - Molecular …, 2019 - ncbi.nlm.nih.gov
Objective Nonalcoholic fatty liver disease (NAFLD) is becoming a leading cause of
advanced chronic liver disease. The progression of NAFLD, including nonalcoholic …
advanced chronic liver disease. The progression of NAFLD, including nonalcoholic …
[引用][C] Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
D Lindén, A Ahnmark, P Pingitore, E Ciociola… - MOLECULAR …, 2019 - iris.unilink.it
Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and
fibrosis in Pnpla3 I148M knock-in mice IRIS IRIS Home Sfoglia Macrotipologie & tipologie …
fibrosis in Pnpla3 I148M knock-in mice IRIS IRIS Home Sfoglia Macrotipologie & tipologie …
[引用][C] Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
D Lindén, A Ahnmark, P Pingitore, E Ciociola… - Molecular …, 2019 - cir.nii.ac.jp
Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis
and fibrosis in Pnpla3 I148M knock-in mice | CiNii Research CiNii 国立情報学研究所 学術 …
and fibrosis in Pnpla3 I148M knock-in mice | CiNii Research CiNii 国立情報学研究所 学術 …
Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
D Lindén, A Ahnmark, P Pingitore… - Molecular …, 2019 - pubmed.ncbi.nlm.nih.gov
Objective Nonalcoholic fatty liver disease (NAFLD) is becoming a leading cause of
advanced chronic liver disease. The progression of NAFLD, including nonalcoholic …
advanced chronic liver disease. The progression of NAFLD, including nonalcoholic …
Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
D Linden, A Ahnmark, P Pingitore, E Ciociola… - MOLECULAR …, 2019 - air.unimi.it
Objective: Nonalcoholic fatty liver disease (NAFLD) is becoming a leading cause of
advanced chronic liver disease. The progression of NAFLD, including nonalcoholic …
advanced chronic liver disease. The progression of NAFLD, including nonalcoholic …
[PDF][PDF] Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
D Lindén, A Ahnmark, P Pingitore, E Ciociola, I Ahlstedt… - 2019 - core.ac.uk
Objective: Nonalcoholic fatty liver disease (NAFLD) is becoming a leading cause of
advanced chronic liver disease. The progression of NAFLD, including nonalcoholic …
advanced chronic liver disease. The progression of NAFLD, including nonalcoholic …
Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice.
D Lindén, A Ahnmark, P Pingitore, E Ciociola… - Molecular …, 2019 - europepmc.org
Objective Nonalcoholic fatty liver disease (NAFLD) is becoming a leading cause of
advanced chronic liver disease. The progression of NAFLD, including nonalcoholic …
advanced chronic liver disease. The progression of NAFLD, including nonalcoholic …
[PDF][PDF] Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
D Lindén, A Ahnmark, P Pingitore, E Ciociola, I Ahlstedt… - 2019 - air.unimi.it
Objective: Nonalcoholic fatty liver disease (NAFLD) is becoming a leading cause of
advanced chronic liver disease. The progression of NAFLD, including nonalcoholic …
advanced chronic liver disease. The progression of NAFLD, including nonalcoholic …